Back to Search

CORT

Corcept Therapeutics Inc.
Data: 2026-04-29
$46.94
Price
0.84%
Change
$91.00
52W High
$28.66
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Quick Stats
Apr 29, 2026

62.7

AI Score

BUY

0.16

Volume Ratio

May 04, 2026

Next Earnings

22

+ve Days (30d)

8

-ve Days (30d)

CORT Stock Summary

Last updated

CORT is currently trading at $46.94, positioned below its 200-day moving average of $60.92, suggesting bearish momentum. The stock has a 52-week range of $28.6601 to $91.

Technical Analysis: The 50-day moving average stands at $38.85, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CORT at 62.7/100 with a BUY recommendation.

CORT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CORT Price vs Max Options Open Interest
CORT Max Change In Options Open Interest

CORT Options - Sort by Max open Interest (near term)

29th April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CORT Daily Out of Money Options - Sort by Max open Interest (near term)

29th April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CORT Daily In the Money Options - Sort by Max open Interest (near term)

29th April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CORT Most Active Options by Volume(near term)

29th April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Corcept Therapeutics Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CORT Moving Averages Analysis

Corcept Therapeutics Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 29, 2026

CORT (Corcept Therapeutics Inc.) Simple Moving Averages

Moving Averages are last updated Apr 29, 2026

Days MA
10 45.91
20 44.15
30 41.58
50 38.85
100 46.95
200 60.92

CORT Fundamental Analysis

P/E (Forward) 129.8701
P/E (Trailing) 56.3659
Market Cap ($) 5.0 billion
Earnings/Share ($) 0.82
Net Proft Margin (%) 0.1309
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.406
EPS Estimate Next Year ($) 1.608
WallStreet Target Price ($) 67.4
Most Recent Quarter